3D Tumor Spheroid Assay for Immune Cell Migration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying immune cell migration and tumor cytotoxicity in cancer research often rely on two-dimensional models that do not accurately reflect the complexity of three-dimensional tumors, leading to inadequate understanding of immune cell infiltration and tumor immune evasion, which limits the effectiveness of immunotherapy across all cancer types and patients.
Innovation Solution
A method and labware system that allows for the investigation of therapeutic agents, such as immune cells or drugs, on tumor cells growing in three-dimensional spheroid conformation, enabling the detection of active migration and cytotoxicity in a single, high-throughput, easy-to-use system that mimics in vivo conditions by using a cell culture article with a porous membrane insert to simulate biological barriers like the blood-brain barrier.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If two-dimensional tumor cell systems are used to study immune cell migration and cytotoxicity, then the assay simplicity and ease of operation are improved, but the accuracy and reliability of the model in reflecting in vivo conditions deteriorates
Solution Approach 1:
The patent transitions from traditional two-dimensional tumor cell monolayers to three-dimensional tumor spheroid models. This dimensional change allows immune cells to migrate through and interact with tumor cells in a more physiologically relevant manner, accurately reflecting the complex architecture and barriers of in vivo tumors while maintaining assay feasibility through standardized spheroid formation protocols
2Reliability
If three-dimensional tumor cell systems are used to study immune cell infiltration, then the model accuracy and reliability are improved, but the device complexity and assay difficulty increase
Solution Approach 1:
The assay is segmented into distinct functional components: tumor spheroid formation in separate wells, immune cell preparation and loading into inserts, co-culture incubation, and readout measurements. This segmentation allows each step to be optimized and standardized independently, reducing overall assay complexity while maintaining the physiological relevance of the three-dimensional model
Solution Approach 2:
The patent uses porous membrane inserts as an intermediary component to facilitate controlled interaction between immune cells and tumor spheroids. The inserts allow immune cells to migrate through a defined barrier toward the tumor spheroid, providing a standardized interface that simplifies the complex process of studying immune cell infiltration into three-dimensional tumor structures
3Ease of operation
If traditional separate assays are used to study homing and cytotoxicity, then the ease of operation is improved, but the loss of time and productivity deteriorates
Solution Approach 1:
The patent merges previously separate homing assays and cytotoxicity assays into a single integrated co-culture system. Immune cells are co-cultured with tumor spheroids in the same well, allowing simultaneous assessment of both migration toward the tumor (homing) and direct killing of tumor cells (cytotoxicity) in one experiment, thereby reducing time and resource requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a more in vivo-like testing model for immune cell and drug interactions with tumors, enhancing the understanding of tumor cytotoxicity and immune evasion, and identifying effective therapeutic agents that can cross biological barriers, thus improving the efficacy of cancer treatments.
Implementation Method 1
detecting active migration of the therapeutic agent from the insert into the cell culture article chamber
Implementation Method 2
detecting infiltration of the therapeutic agent, such an immune cell, into the tumor cell spheroid
Implementation Method 3
detecting tumor cell response. In embodiments, tumor cell response may be tumor cell lysis
Data Source
Figure 1A~1C
Figure 2
Figure 3A~3B
AI summary
The present disclosure relates to methods for performing assays for active migration and cytotoxicity of a therapeutic agent towards tumor cells, e.g., immune cell and/or drug homing, migration, and tumor cytotoxicity. The methods are performed in labware that provide opportunities for a therapeutic agent, such as an immune cell or a drug, to migrate toward tumor cells, including tumor cells growing in a 3D spheroid conformation. The methods allow for, among other uses, the investigation of the effects of a therapeutic agent, such as immune cells or a drug, on tumor cells, and enable the investigation of homing, tumor cytotoxicity, and tumor immune evasion in a single, easy-to-use, high throughput system for more in vivo-like testing.